Emmanuelle Tchernonog
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 11
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 7
-
- Viral-associated cancers and disorders 5
- CAR-T cell therapy research 3
-
- Immunodeficiency and Autoimmune Disorders 2
- Immune Cell Function and Interaction 2
- Galectins and Cancer Biology 2
-
- Occupational and environmental lung diseases 2
- Co-authors
- Guillaume CartronSteven Le GouillCharles HerbauxBettina FabianiCamille LaurentPaul CoppoRory McCullochFranck Morschhauser
- Journals
- Journal of Clinical Oncology (1 paper)Blood (5 papers)International Journal of Molecular Sciences (1 paper)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Emmanuelle Tchernonog
16 papers receiving 280 citations
Peers
Comparison fields: 5 of 38
- Pathology and Forensic Medicine 203
- Genetics 90
- Oncology 214
- Hematology 24
- Immunology 43
Countries citing papers authored by Emmanuelle Tchernonog
This map shows the geographic impact of Emmanuelle Tchernonog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Tchernonog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Tchernonog more than expected).
Fields of papers citing papers by Emmanuelle Tchernonog
This network shows the impact of papers produced by Emmanuelle Tchernonog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Tchernonog. The network helps show where Emmanuelle Tchernonog may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emmanuelle Tchernonog, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 23 | |
| 9 | 2021 | 3 | |
| 10 | 2020 | 75 | |
| 11 | 2019 | 9 | |
| 12 | 2019 | 6 | |
| 13 | Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma | 2019 | 3 |
| 14 | 2018 | 6 | |
| 15 | 2018 | 1 | |
| 16 | 2016 | 67 | |
| 17 | 2016 | 78 |
About Emmanuelle Tchernonog
Emmanuelle Tchernonog is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology, having authored 17 papers that have together received 282 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (7 papers), Viral-associated cancers and disorders (5 papers), CAR-T cell therapy research (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Occupational and environmental lung diseases (2 papers), Immune Cell Function and Interaction (2 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (203 citations), Genetics (90 citations) and Oncology (214 citations). Emmanuelle Tchernonog has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Guillaume Cartron, Steven Le Gouill, Charles Herbaux, Bettina Fabiani, Camille Laurent, Paul Coppo, Rory McCulloch, Franck Morschhauser, Mary Callanan and Cédric Rossi. Their work appears in journals such as Journal of Clinical Oncology, Blood and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.